Cibus, Inc. – NASDAQ:CBUS

Add to watchlist

$1.39

-0.97

-41.1%

Market open

Closed in about 5 hours

-76.26%

month

-76.26%

quarter

-88.62%

year

Market Cap	71.25M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-18.55

Revenue	2.32M
EBITDA	-327.60M
Income	-285.66M
Revenue Q/Q	1197.61%
Revenue Y/Y	1289.22%

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	-14120.82%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Cibus, Inc. (NASDAQ:CBUS): Profit margin
Jun 2023	197K	-20.50M	-10410.66%
Sep 2023	475K	-34.52M	-7269.05%
Dec 2023	1.10M	-207.19M	-18784.77%
Mar 2024	545K	-23.43M	-4300%

Cibus Financials Estimate

Q Y

Cibus, Inc. (NASDAQ:CBUS): Analyst Estimates
2025	8.69M	-88.07M	-1013.46%
2026	42.15M	-63.73M	-151.18%

Analysts Price target
Financials & Ratios estimates

Cibus, Inc. (NASDAQ:CBUS): Debt to assets
Jun 2023	814268000	193.08M	23.71%
Sep 2023	796235000	203.74M	25.59%
Dec 2023	544411000	206.11M	37.86%
Mar 2024	533034000	213.20M	40%

Cibus, Inc. (NASDAQ:CBUS): Cash Flow
Jun 2023	-11.74M	58.82M	1.75M
Sep 2023	-15.07M	-3.31M	-619K
Dec 2023	-17.01M	-449K	18.27M
Mar 2024	-13.48M	-228K	5.51M

Cibus alternative data

Cibus, Inc. (NASDAQ:CBUS): Employee count
Dec 2023	236
Jan 2024	236
Feb 2024	236
Mar 2024	183
Apr 2024	183
May 2024	183
Jun 2024	183
Jul 2024	183

Cibus, Inc. (NASDAQ:CBUS): Insider trades (number of shares)
Period	Buy	Sel
Jun 2024	0	2000
Jul 2024	0	4000
Nov 2024	0	13847
Dec 2024	0	8050

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	9 Dec 2024	PRANTE GERHARD director director	Class A Common Stock	1,150	$4.15	$4,773
Sale	6 Dec 2024	PRANTE GERHARD director director	Class A Common Stock	1,150	$3.86	$4,439
Sale	5 Dec 2024	PRANTE GERHARD director director	Class A Common Stock	1,150	$4	$4,600
Sale	4 Dec 2024	PRANTE GERHARD director director	Class A Common Stock	1,150	$4.39	$5,049
Sale	3 Dec 2024	PRANTE GERHARD director director	Class A Common Stock	1,150	$4.69	$5,394
Sale	2 Dec 2024	PRANTE GERHARD director director	Class A Common Stock	2,300	$4.46	$10,258
Sale	27 Nov 2024	PRANTE GERHARD director director	Class A Common Stock	1,150	$4.5	$5,175
Sale	26 Nov 2024	PRANTE GERHARD director director	Class A Common Stock	1,150	$4.57	$5,256
Sale	25 Nov 2024	PRANTE GERHARD director director	Class A Common Stock	1,150	$4.19	$4,819
Sale	22 Nov 2024	PRANTE GERHARD director director	Class A Common Stock	1,150	$4.32	$4,968

Cibus
Earnings Call Transcripts

Quarter	Transcript
Q1 2024 11 May 2024	Q1 2024 Earnings Call Transcript
Q4 2023 21 Mar 2024	Q4 2023 Earnings Call Transcript
Q3 2023 11 Nov 2023	Q3 2023 Earnings Call Transcript
Q2 2023 11 Aug 2023	Q2 2023 Earnings Call Transcript

CBUS earnings call transcripts

Cibus
Latest News

Monday, 16 December 2024
07:00	Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers	globenewswire.com
Tuesday, 19 November 2024
07:30	Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape	globenewswire.com
Monday, 18 November 2024
07:00	Cibus to Participate in the 13th Annual Roth Technology Conference	globenewswire.com
Saturday, 9 November 2024
13:38	Cibus, Inc. (CBUS) Q3 2024 Earnings Call Transcript	seekingalpha.com
Thursday, 7 November 2024
18:57	Cibus (CBUS) Q3 Earnings and Revenues Top Estimates	zacks.com
16:05	Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024	globenewswire.com
Tuesday, 5 November 2024
08:00	Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola	globenewswire.com
Thursday, 24 October 2024
07:00	Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call	globenewswire.com
Monday, 21 October 2024
07:00	Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities	globenewswire.com
Friday, 11 October 2024
08:49	Cibus Technology to be Featured on InnovAction Stage at the Euroseeds2024 Congress	globenewswire.com
Monday, 23 September 2024
13:01	Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly	globenewswire.com
Wednesday, 18 September 2024
08:25	Cibus Announces Pricing of Public Offering of Class A Common Stock	globenewswire.com
Tuesday, 17 September 2024
16:46	Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock	globenewswire.com
Tuesday, 10 September 2024
07:00	Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape	globenewswire.com
Monday, 12 August 2024
16:05	Cibus to Participate in Upcoming August Investor Events	globenewswire.com
Saturday, 10 August 2024
11:19	Cibus, Inc. (CBUS) Q2 2024 Earnings Call Transcript	seekingalpha.com
Thursday, 8 August 2024
19:11	Cibus (CBUS) Reports Q2 Loss, Tops Revenue Estimates	zacks.com
Tuesday, 6 August 2024
07:36	Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice	globenewswire.com
Thursday, 1 August 2024
07:00	Cibus to Report Second Quarter 2024 Financial Results on August 8, 2024 After the Market Close and Host Conference Call	globenewswire.com
Friday, 26 July 2024
12:30	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS	globenewswire.com
Thursday, 25 July 2024
07:25	Levi & Korsinsky Reminds Cibus, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CBUS	accesswire.com
Wednesday, 24 July 2024
20:57	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS	prnewswire.com
Tuesday, 23 July 2024
18:30	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS	accesswire.com
Monday, 22 July 2024
07:30	Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud	accesswire.com
Saturday, 20 July 2024
21:01	An Investigation Has Commenced on Behalf of Cibus, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CBUS Losses.	accesswire.com
10:48	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS	globenewswire.com
Thursday, 18 July 2024
22:00	Shareholder Rights Advocates at Levi & Korsinsky Investigate Cibus, Inc. (CBUS) Regarding Possible Securities Fraud Violations	accesswire.com
21:37	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS	prnewswire.com
Wednesday, 17 July 2024
11:45	Levi & Korsinsky Reminds Cibus, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CBUS	accesswire.com
Sunday, 14 July 2024
12:00	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cibus, Inc. - CBUS	accesswire.com

Ideas & Opinions

Seeking Alpha 12 Jan 2024

Cibus: Expanding Opportunities And Growing Accessible Market

Frequently Asked Questions (FAQ)

What's the price of Cibus stock today?

One share of Cibus stock can currently be purchased for approximately $1.39.
When is Cibus's next earnings date?

Unfortunately, Cibus's (CBUS) next earnings date is currently unknown.
Does Cibus pay dividends?

No, Cibus does not pay dividends.
How much money does Cibus make?

Cibus has a market capitalization of 71.25M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1057.32% to 1.82M US dollars.
What is Cibus's stock symbol?

Cibus, Inc. is traded on the NASDAQ under the ticker symbol "CBUS".
What is Cibus's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Cibus?

Shares of Cibus can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Cibus have?

As Jul 2024, Cibus employs 183 workers.
When Cibus went public?

Cibus, Inc. is publicly traded company for more then 8 years since IPO on 20 Jul 2017.
What is Cibus's official website?

The official website for Cibus is cibus.com.
Where are Cibus's headquarters?

Cibus is headquartered at 6455 Nancy Ridge Drive, San Diego, CA.
How can i contact Cibus?

Cibus's mailing address is 6455 Nancy Ridge Drive, San Diego, CA and company can be reached via phone at 858 450 0008.

Cibus, Inc.

cibus.com

Exchange:

NASDAQ

Full time employees:

183

Industry:

Biotechnology

Sector:

Healthcare

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

858 450 0008

6455 Nancy Ridge Drive
San Diego, CA 92121

CIK: 0001705843
ISIN: US17166A1016
CUSIP: 17166A101